findmyKOL
Clinical trialNCT02059642CompletedPhase 2/PHASE3Interventional

A 6 Week Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD ( Attention Deficit/Hyperactivity )

SponsorAlcobra Ltd.Enrollment300ADHDAttention-Deficit/Hyperactivity Disorder, Predominantly Inattentive Type
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

20 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Israel
  • Neurocognitive Unit Rambam Mc

    Haifa, Israel

  • Adhd Unit Geha Mc

    Petah Tikva, Israel

United States
  • Sarkis Clinical Trials

    Gainesville, Florida, United States

  • Miami Research

    South Miami, Florida, United States

  • Capstone Clinical Research

    Libertyville, Illinois, United States

  • Psychiatric Associates

    Overland Park, Kansas, United States

  • University Kentucky Psychiatry

    Lexington, Kentucky, United States

  • Pediatric Psychopharmacology & Adult Adhd Program, Massachusetts General Hospital

    Boston, Massachusetts, United States

  • Rochester Center for Behavioral Medicine

    Rochester Hills, Michigan, United States

  • Behavioral Medicine Center

    Troy, Michigan, United States

  • St. Charles Psychiatric Associates

    Saint Charles, Missouri, United States

  • Center for Psychiatry and Behavioral Medicine

    Las Vegas, Nevada, United States

  • Bioscience Research

    Mount Kisco, New York, United States

  • Duke University

    Durham, North Carolina, United States

  • Richard H Weisler, Md, Pa

    Raleigh, North Carolina, United States

  • Sequoia Behavioral Healthcare

    Media, Pennsylvania, United States

  • Futureresearch Trials

    Austin, Texas, United States

  • Futureresearch Trials Dallas, Lp

    Dallas, Texas, United States

  • Bayou City Research

    Houston, Texas, United States

  • Neuroscience, Inc. (nsi)

    Herndon, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Mar 2014
Primary completion
30 Sept 2014
Completion
30 Sept 2014
Last update posted
28 Mar 2017
Registered enrollment
300
Registry id
NCT02059642

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.